760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)

The Department of Veterans Affairs (VA) Veterans Health Administration, specifically Veterans Integrated Service Network 15, is issuing a pre-solicitation notice for procurement of Armour Thyroid tablets to be delivered to the Leavenworth CMOP facility. The solicitation (36C77025Q0079) seeks five different dosage strengths of thyroid tablets ranging from 30-32.5mg to 180mg, with quantities varying between 192 and 1,728 bottles of 100 tablets. Potential vendors must be registered in SAM.gov and possess a state wholesale distributor license compliant with the Drug Supply Chain Security Act. Submission requirements include completing SF1449, providing a pricing schedule in Excel format, submitting a state wholesale distributor license, and including a Buy American Act certificate if applicable. The estimated solicitation issue date is December 18, 2024, with responses due by December 27, 2024 at 4:00 PM Central Time.

The procurement is classified under NAICS category 325412 (Pharmaceutical Preparation Manufacturing) and PSC code 6505 (Drugs and Biologicals), representing a full and open competition with no specific set-aside designation. Large businesses will be required to submit a subcontracting plan, and all vendors must be prepared to deliver products within 10 days after receipt of order. While specific award value is not detailed in the pre-solicitation notice, the procurement involves multiple dosage strengths of Armour Thyroid tablets manufactured by Abbvie/Armour. Vendors will need to email their complete submissions directly to the contract specialist, demonstrating compliance with all specified requirements. The competitive nature of the solicitation suggests potential for multiple vendors to compete for this pharmaceutical supply contract.